Select Page

Targeting the Bone Marrow
microenvironment

 

for augmentation of normal hematopoiesis

and treatment of leukemia

Our focus

Building on years of our research, we focus on the following two indications: 

HSC Expansion

Expansion of hematopoietic stem cells (HSCs) from umbilical cord blood or other sources for HSC transplantation for various diseases 

Leukemia treatment

Design and testing of inhibitors of the integrin signaling pathway for the treatment of leukemia

HSC expansion

Expansion of hematopoietic stem cells (HSCs) from umbilical cord blood or other sources for HSC transplantation for various diseases 

leukemia treatment

Design and testing of inhibitors of the integrin signaling pathway for the treatment of leukemia

Daniela Krause, MD, PhD

Professor
Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Goethe University Frankfurt, Germany

Keertik Fulzele, PhD

Cancer Center,
Massachusetts General Hospital,
Harvard Medical School, Boston, MA

Contact Us

Contact us for additional information.

Contact us

info@myelox.com